Cite
HARVARD Citation
Ungar, B. et al. (n.d.). P486 Response to vedolizumab therapy in patients with inflammatory bowel disease: Impact of drug levels, anti-drug antibodies and α4β7 target occupancy. Journal of Crohn's and colitis. pp. S350-S351. [Online].